Different contributions of chemokine N‐terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3
- 23 March 2018
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 175 (9), 1419-1438
- https://doi.org/10.1111/bph.14132
Abstract
Chemokines and their receptors form an intricate interaction and signaling network that plays critical roles in various physiological and pathological cellular processes. The high promiscuity and apparent redundancy of this network makes probing individual chemokine/receptor interactions and functional effects, as well as targeting individual receptor axes for therapeutic applications, challenging. Despite poor sequence identity, the N-terminal regions of chemokines, which play a key role in their activity and selectivity, harbor several conserved features. Thus far, little is known regarding the molecular basis of their interactions with conventional vs. atypical chemokine receptors or the conservation of their contributions across chemokine-receptor pairs. In this study, using a broad panel of chemokine variants and modified peptides derived from the N-terminal region of chemokines CXCL12, CXCL11, and vCCL2, we compare the role of various features in binding and activation of their shared receptors, the two canonical G protein-signaling receptors, CXCR4 and CXCR3, as well as the atypical scavenger receptor CXCR7/ACKR3, which shows exclusively arrestin-dependent activity. We provide exhaustive molecular insights into the plasticity of the ligand-binding pockets of these receptors, their chemokine binding modes, and their activation mechanisms. We show that, although the chemokine N-terminal region is a critical determinant, neither the most proximal residues nor the N-loop are essential for ACKR3 binding and activation, as opposed to CXCR4 and CXCR3. These results suggest a different interaction mechanism between this atypical receptor and its ligands and illustrates its strong propensity to activation.Funding Information
- Fonds pour la Formation à la Recherche dans l’Industrie et dans l’Agriculture
- Fonds National de la Recherche Luxembourg (AFR‐11274579, AFR‐3004509, AFR‐5907281, INTER/FWO/1510358798)
- Fonds De La Recherche Scientifique - FNRS (MIS‐F.4510.14)
- Canadian Institutes of Health Research (MOP123421)
- National Institutes of Health (F30CA196040, R01 AI058072, T32 GM080202)
- Fonds De La Recherche Scientifique - FNRS (MIS‐F.4510.14)
- KU Leuven (PF/10/018)
This publication has 79 references indexed in Scilit:
- The Chemokine Superfamily RevisitedImmunity, 2012
- Cell Contact-dependent Functional Selectivity of β2-Adrenergic Receptor Ligands in Stimulating cAMP Accumulation and Extracellular Signal-regulated Kinase PhosphorylationOnline Journal of Public Health Informatics, 2012
- Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide AntagonistsScience, 2010
- Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligandsOncogene, 2010
- CXCR7 Functions as a Scavenger for CXCL12 and CXCL11PLOS ONE, 2010
- β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7Proceedings of the National Academy of Sciences of the United States of America, 2009
- Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12Science Signaling, 2008
- A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentThe Journal of Experimental Medicine, 2006
- Processing by CD26/dipeptidyl‐peptidase IV reduces the chemotactic and anti‐HIV‐1 activity of stromal‐cell‐derived factor‐1αFEBS Letters, 1998
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998